598 related articles for article (PubMed ID: 33525562)
1. Lithium and Therapeutic Targeting of GSK-3.
Snitow ME; Bhansali RS; Klein PS
Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
[TBL] [Abstract][Full Text] [Related]
2. Validating GSK3 as an in vivo target of lithium action.
O'Brien WT; Klein PS
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1133-8. PubMed ID: 19754466
[TBL] [Abstract][Full Text] [Related]
3. Lithium and synaptic plasticity.
Salinas PC; Hall AC
Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
[TBL] [Abstract][Full Text] [Related]
4. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
Marmol F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1761-71. PubMed ID: 18789369
[TBL] [Abstract][Full Text] [Related]
5. The history of lithium therapy.
Shorter E
Bipolar Disord; 2009 Jun; 11 Suppl 2(Suppl 2):4-9. PubMed ID: 19538681
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
[TBL] [Abstract][Full Text] [Related]
7. Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta).
Serretti A; Drago A; De Ronchi D
Curr Med Chem; 2009; 16(15):1917-48. PubMed ID: 19442155
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte phosphoglucomutase activity of bipolar I patients currently using lithium or carbamazepine.
Montero-Lomelí M; Galvão D; Morais BB; Nardi AE
Braz J Med Biol Res; 2007 Jan; 40(1):19-25. PubMed ID: 17224992
[TBL] [Abstract][Full Text] [Related]
9. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
10. Molecular effects of lithium.
Quiroz JA; Gould TD; Manji HK
Mol Interv; 2004 Oct; 4(5):259-72. PubMed ID: 15471909
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
Malhi GS; Outhred T
CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
[TBL] [Abstract][Full Text] [Related]
12. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.
Gurvich N; Klein PS
Pharmacol Ther; 2002 Oct; 96(1):45-66. PubMed ID: 12441177
[TBL] [Abstract][Full Text] [Related]
13. The Wnt signaling pathway in bipolar disorder.
Gould TD; Manji HK
Neuroscientist; 2002 Oct; 8(5):497-511. PubMed ID: 12374432
[TBL] [Abstract][Full Text] [Related]
14. Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary.
Pavuluri MN; Lee MS; Pandey G
Bipolar Disord; 2015 Mar; 17(2):224-32. PubMed ID: 25523965
[No Abstract] [Full Text] [Related]
15. [Lithium: 55 years of history in the therapy of bipolar affective disorder].
Mármol F
Med Clin (Barc); 2006 Jul; 127(5):189-95. PubMed ID: 16834956
[TBL] [Abstract][Full Text] [Related]
16. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.
Bortolozzi A; Fico G; Berk M; Solmi M; Fornaro M; Quevedo J; Zarate CA; Kessing LV; Vieta E; Carvalho AF
Pharmacol Rev; 2024 May; 76(3):323-357. PubMed ID: 38697859
[TBL] [Abstract][Full Text] [Related]
17. John Cade and lithium.
Walter G
Psychiatr Serv; 1999 Jul; 50(7):969. PubMed ID: 10402625
[No Abstract] [Full Text] [Related]
18. Lymphocyte Phospho-Ser-9-GSK-3β/Total GSK-3β Protein Levels Ratio Is Not Affected by Chronic Lithium or Valproate Treatment in Euthymic Patients With Bipolar Disorder.
Azab AN; Vainer E; Agam G; Bersudsky Y
J Clin Psychopharmacol; 2017 Apr; 37(2):226-230. PubMed ID: 28106616
[TBL] [Abstract][Full Text] [Related]
19. Is phosphoadenosine phosphate phosphatase a target of lithium's therapeutic effect?
Shaltiel G; Deutsch J; Rapoport SI; Basselin M; Belmaker RH; Agam G
J Neural Transm (Vienna); 2009 Nov; 116(11):1543-9. PubMed ID: 19756369
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.
Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P
J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
